HEALTH/FITNESS

Photo Credit; Getty Images

Just days after OpenAI’s entry into the space, Anthropic has unveiled healthcare features for Claude that allow the AI to access and analyze sensitive medical records. While this signals a major technological push into life sciences, the move highlights the growing role of AI in high-stakes fields where accuracy and privacy are paramount. The launch positions healthcare as the ultimate testing ground for whether generative AI can safely handle the world's most personal data.

Both tools will allow users to share information from health records and fitness apps, including Apple’s Health app, to personalize health-related conversations.

At the same time, the expansion comes amid heightened scrutiny over whether AI systems can safely interpret medical information and avoid offering harmful guidance.

Photo Credit; Getty Images

OpenAI has introduced a health-focused feature in the U.S. designed to provide personalized advice by analyzing users' medical records and data from fitness apps like MyFitnessPal. While the company emphasized that "Chat Health" data is stored separately and not used to train its AI models, the launch has sparked warnings from privacy campaigners. OpenAI also clarified that the tool is strictly for informational purposes and is not intended to provide professional medical "diagnosis or treatment.”

Photo Credit: Getty Images

The Maldives has implemented a groundbreaking nationwide generational tobacco prohibition, banning anyone born on or after January 1, 2007, from smoking tobacco. The archipelago's health ministry announced on Saturday that it would be illegal for these younger generations to use, buy, or sell tobacco within the country. This initiative makes the Maldives the only nation globally to enforce such a comprehensive measure, reflecting the government's "strong commitment to protecting young people from the harms of tobacco," the ministry stated.

Photo Credit: Getty Images

Novo Nordisk, the maker of the diabetes and weight-loss drug Ozempic, is facing mounting legal pressure as more than 2,000 people have filed lawsuits alleging the drug caused serious, life-altering health complications. The combined damages being sought are estimated to exceed $2 billion, making the case one of the largest pharmaceutical lawsuits in recent years.

Photo Credit: Getty Images

This Barbie is bringing attention to the issue. And they're doing it with the first-ever doll with type 1 diabetes, the newest model in Mattel's inclusive Fashionista Barbie collection.